follow-up of patients with hemophilia b treated with fidanacogene elaparvovec aav gene therapy
Published 2 years ago • 266 plays • Length 3:58Download video MP4
Download video MP3
Similar videos
-
23:28
gene therapy for treatment of hemophilia: an introduction to aav vector gene transfer
-
20:34
gene therapy for treatment of hemophilia: aav vector gene therapy application to hemophilia
-
2:17
one year follow-up of patients with hemophilia b following spk-9001 gene transfer
-
1:57
aav gene therapies for hemophilia a and b
-
2:11
improved joint health following dirloctocogene samoparvovec gene therapy in patients with hemophilia
-
2:23
current hurdles in aav-based gene therapy for hemophilia
-
5:33
liver safety case report from the phase 3 hope-b gene therapy trial in adults with hemophilia b
-
18:21
gene therapy for the treatment of hemophilia b: andrew m. davidoff, md at tedxsonomacounty
-
0:52
etranacogene dezaparvovec | hemgenix | first gene therapy drug | 3.2 million usd
-
28:50
gene therapy in hemophilia: common concerns in gene therapy
-
5:39
health-related quality of life in adults with hemophilia b after gene therapy
-
3:07
aav-based gene therapy in hemophilia a and b: valoctocogene roxaparvovec & etranacogene dezaparvovec
-
36:32
gene therapy for fviii
-
1:09:37
gene therapy in hemophilia: an apsth isth sponsored symposium
-
50:15
hemophilia gene therapy- key components of clinical care
-
24:40
data from phase 3 gene therapy trial in hemophilia b patients very encouraging
-
3:38
gene therapy: an end to hemophilia
-
18:10
gene therapy for hemophilia
-
5:34
steven pipe: etranacogene dezaparvovec gene therapy for hemophilia b